45P Efficacy of derazantinib in intrahepatic cholangiocarcinoma patients with FGFR2 mutations or amplifications: Pooled analysis of clinical trials and early access programs

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 31; p. S1231
Main Authors Droz Dit Busset, M., Shaib, W.L., Harris, W.P., Damjanov, N., Borad, M., Vogel, A., Bridgewater, J.A., Sellmann, L., Dadduzio, V., Borner, M., Snider, J., Cantero, F., Saulay, M., Braun, S., Mazzaferro, V., Javle, M.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.10.2020
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2020.08.2204